Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Kraig Labs (OTCQB: KBLB) senior management will travel to Southeast Asia to oversee continued recombinant spider silk production expansion
-
Kraig Labs (OTCQB: KBLB) released a CEO letter packed with significant progress in production, R&D, and commercial developments for a transformative 2025
-
Kraig Labs (OTCQB: KBLB) developed a new recombinant spider silk parental line, purpose-built for large-scale commercial production
-
Kraig Labs (OTCQB:KBLB) officially received a business license to begin Cambodian operations to expand its spider silk production
-
Kraig Labs (OTCQB: KBLB) successfully completed its March/April spider silk production run and is currently well underway with its May production cycle
-
Kraig Labs (OTCQB:KBLB) expands spider silk production capacity
-
Kraig Labs (OTCQB:KBLB) successfully rolled out its next-generation molecular biology and gene-splicing platform
-
Kraig Labs (OTCQB: KBLB) appoints Dr. Xiaoli Zhang as Director of Molecular Biology
-
Kraig Labs (OTCQB: KBLB) secured four registered trademarks for SpydaSilk®, a key commercialization milestone for its revolutionary spider silk technology
-
Kraig Labs (OTCQB: KBLB) successfully engineered the largest known spider silk gene insert into silkworm.